You are here

TripSitter Clinic Ltd.

TripSitter Clinic Ltd.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Technology
Symbol: 
KETA
CSE Index: 
Currency: 

TripSitter Clinic Ltd., through its wholly-owned subsidiary TripSitter Clinic Corp, is at the forefront of two emerging sectors: telehealth and psychedelic medicine. The Company’s consultative virtual clinic, TripSitter.Clinic, is a SaaS platform that provides care, monitoring and coaching while connecting patients with licensed physicians in the United States who can evaluate for a prescribed psychedelic treatment program of therapeutic low-dose ketamine medication. TripSitter is not a primary care physician (PCP). TripSitter.Clinic requires prospective patients to provide a diagnosis from their PCP along with other health information to their chosen TripSitter physician during the initial intake process. When a patient is approved for treatment by their physician, TripSitter.Clinic connects the patient with experts who also use the platform to consult and coordinate with the patient and their physician.

You are here

TripSitter Clinic Ltd. (KETA)

SEDAR Information

Company Info

Address
77 King Street West - Suite 700
Toronto, ON M5K 1G8
Canada
Phone
(416) 480-2488
Email
Support@tripsitter.clinic
Website
https://www.tripsitter.clinic
Listing date
Monday, November 29, 2021
Transfer Agent
Olympia Trust Company

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
33,290,868
Reserved for Issuance: 
9,532,427

Company Officers

Dr. John Huber, CEO
Umer Aziz, Interim CFO

Bulletins

26/11/2021

2021-1141 - New Listing - TripSitter Clinic Ltd. (KETA)

Le 26 novembre/November 2021

The common shares of TripSitter Clinic Ltd. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

TripSitter is a consultative virtual clinic and tele-health platform that connects prospective patients to a licensed physician in the United States who can evaluate for a prescribed treatment program of low-dose, oral ketamine medication.

Advertisement

Publicité

Latest CSE News